Sara Zelkovic | Director, Communications and Investor Relations |
Michel Lussier | Interim Chief Executive Officer |
Charlie Morris | Chief Medical Officer |
David Georges | Vice President of Finance and Administration |
Raju Prasad | William Blair |
Greetings and welcome to the Celyad Oncology First Half 2022 Financial Results. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder this conference is being recorded. I would now like to turn the conference over to your host, Sara Zelkovic, Director of Communications & Investor Relations for Celyad Oncology. Thank you.